In addition, Rigat et al (12) investigated the effects of GM2A in animal models of NEC and demonstrated that the administration of recombinant GM2A inhibited lethal rat intestinal necrotic injury induced by LPS and PAF. The gene discussed is GM2A; the disease is necrotizing enterocolitis.